Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer
There is no question that COVID-19 transformed how we collectively delivered care in 2020. Global venture capital funding for digital health companies in the first nine months of 2020, alone, was a record-breaking $10.3 billion with top-funded categories of telemedicine, data analytics and mHealth apps.1 While data show that the adoption of electronic prior authorizations and other eService technologies correlates with decreases in time to therapy and overall increases in medication adherence, the application of this technology is happening largely “behind the scenes” — invisible to the patient.
However, the rapid acceleration of digital health technologies over the past 12-24 months presents new opportunities for pharmaceutical patient support programs to leverage technology in ways that are transformative to the patient experience. We have identified several considerations and capabilities that are foundational to pharma-sponsored patient support in the era of healthcare consumerism.
TrialCard Incorporated provides patient affordability, medication access and adherence, patient support, and clinical trial services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has connected nearly 33 million patients with over $15 billion in branded drug savings to date. Our attention to detail, commitment to our clients, and locations in areas that are rich in healthcare talent allow us to provide levels of service that are unsurpassed in our industry. The company is headquartered in Morrisville, North Carolina. For more information about TrialCard, please visit www.trialcard.com.